Undergraduate Students

Ģ��Ƶ Healthcare-Management Case Competition (MHCC) - Date TBD

admin — Thu, 27 Mar 2025 20:14:22 +0000

GCHM and IMHL students and alumni - apply your knowledge in a real-world healthcare challenge.

Online Info Session: Graduate Certificate in Healthcare Management (GCHM)

admin — Thu, 07 Aug 2025 13:32:25 +0000

Join us for an online information session to learn about the Graduate Certificate in Healthcare Management at the Desautels Faculty of Management and Medicine and Health Sciences, Ģ��Ƶ.

ECHO-Autism: The Diagnostic Process

admin — Thu, 07 Aug 2025 15:08:00 +0000

ECHO-Autism: The Diagnostic Process August 21, 2025 12:15 to 1:45 p.m. (ET) Virtual training (online)

ECHO-Autism: Differential Diagnosis

admin — Thu, 07 Aug 2025 15:17:04 +0000

ECHO-Autism: Differential Diagnosis September 11, 2025 1:00 to 2:30 p.m. (ET) Virtual training (online)

Exhibit | ouch ouch ouch

admin — Thu, 13 Mar 2025 12:49:12 +0000

La version française suit.

Online Info Session: International Masters for Health Leadership (IMHL)

admin — Thu, 07 Aug 2025 13:29:38 +0000

Join IMHL Program Director Leslie Breitner for an online information session outlining the International Masters for Health Leadership at Ģ��Ƶ's Desautels Faculty of Manage

6th National Course on Sleep Medicine

admin — Thu, 12 Dec 2024 14:46:27 +0000

This two-day training course is designed to provide and enhance a basic working knowledge of sleep medicine.

8th National Neuromuscular Review Course

admin — Thu, 13 Feb 2025 16:08:29 +0000

Dr. Nicolas Dupré of Laval University, Dr. Karine Garneau of Université de Montréal, and the members of the organizing committee are pleased to announce the 8th National Neuromuscular Review Course.

Hughlings Jackson Lecture 2025: The Basal Ganglia and the Motivation to Act

admin — Mon, 13 Jan 2025 21:40:52 +0000

Established in 1935, the Hughlings Jackson Lecture is The Neuro’s premier scientific lecture. It honours the legacy of British neurologist John Hughlings Jackson (1835-1911) who pioneered the development of neurology as a medical specialty.

Neuro Epilepsy Lecture Series: AI in Epilepsy: From Diagnosis to Continuous Monitoring

admin — Tue, 05 Aug 2025 17:49:37 +0000

The 2024-2025 Neuro Epilepsy Lecture Series will include eight lectures covering hot topics in basic and clinical epilepsy research.

Ģ��Ƶ researchers receive funding from the Canadian Cancer Society for cancer equity research

admin — Mon, 17 Feb 2025 20:31:39 +0000

Co-Principal Investigators Manisha Pahwa, CIHR Research Excellence, Diversity, and Independence Postdoctoral Fellow in the School of Physical and Occupational Therapy, and Professor Ananya Banerjee, from Ģ��Ƶ's Department of Epidemiology, Biostatistics, and Occupational Health, have been awarded $449,604 from the Canadian Cancer Society’s Health Equity Research Grant

Human instruction with artificial intelligence guidance provided best results in neurosurgical training

admin — Wed, 06 Aug 2025 15:14:02 +0000

Study has implications beyond medical education, suggesting other fields could benefit from AI-enhanced training

Artificial intelligence (AI) is becoming a powerful new tool in training and education, including in the field of neurosurgery. Yet a new study suggests that AI tutoring provides better results when paired with human instruction.

Neuro Staff Appreciation Day 2025

admin — Tue, 08 Jul 2025 20:17:29 +0000

Staff Appreciation Day is exclusively for Neuro staff, faculty, nurses, students, and trainees. ID required to enter.

Genetic sequencing project receives more than $8 million in funding

admin — Tue, 18 Mar 2025 14:55:14 +0000

NeuRo Genomics Initiative will help better understand rare and aging-related neurological disorders affecting Canadians

A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of Ģ��Ƶ and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.

Latest Alzheimer’s drug shown less effective in females than males

admin — Tue, 18 Mar 2025 18:27:46 +0000

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.